CANCER Trademark

Trademark Overview


On Thursday, March 14, 2013, a trademark application was filed for CANCER with the United States Patent and Trademark Office. The USPTO has given the CANCER trademark a serial number of 85876328. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 12, 2016. This trademark is owned by Celgene Corporation. The CANCER trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, Medical & Beauty Services & Agricultural Services, Personal, and Legal & Social Services categories with the following description:

Pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations for the treatment of certain blood diseases and cancers

Development and testing services in the fields of biotechnology, chemistry and pharmaceuticals; scientific study and research in the fields of the prevention, treatment and management of illness, health care delivery and the scientific aspects of health care policy, health care cost management and financing as these fields impact on quality of health care; research in the fields of chemicals and pharmaceuticals; research and testing services in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing services for medical and scientific research and development purposes, namely, pharmacogenetic testing, predictive medical testing, personalized medical testing, gene sequencing-based testing and genotyping based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries; scientific res...

Providing on-line information in the field of diagnosis and treatment of cancer; providing an on-line computer database featuring information relating to diagnosis and treatment of cancer; providing medical and pharmaceutical information services; providing links to web sites of others featuring information about the diagnosis and treatment of cancer; providing medical information and pharmaceutical information services, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; disease management programs that provide counseling and information in the field of pharmaceuticals, and distributing written materials in connection therewith; providing an interactive website featuring medical information that enables users to enter, access, track, monitor and generate health and medical information and reports; providing pharmacogenetic testing, predictive medical testing, personalized medical testing, gene sequencing-based testing and g...

Government pharmaceutical programs that provide counseling and information to medical professionals, pharmacists and patients, including counseling and information on consumer product safety issues pertaining to pharmaceuticals, and distributing printed materials in connection therewith
cancer

General Information


Serial Number85876328
Word MarkCANCER
Filing DateThursday, March 14, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 12, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 11, 2013

Trademark Statements


Indication of Colors claimedThe color(s) blue, red and white is/are claimed as a feature of the mark.
Description of MarkThe mark consists of a red universal prohibition symbol with a blue and white globe inside and the word "CANCER" in white with a red line diagonally through it.
Goods and ServicesPharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations for the treatment of certain blood diseases and cancers
Goods and ServicesDevelopment and testing services in the fields of biotechnology, chemistry and pharmaceuticals; scientific study and research in the fields of the prevention, treatment and management of illness, health care delivery and the scientific aspects of health care policy, health care cost management and financing as these fields impact on quality of health care; research in the fields of chemicals and pharmaceuticals; research and testing services in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing services for medical and scientific research and development purposes, namely, pharmacogenetic testing, predictive medical testing, personalized medical testing, gene sequencing-based testing and genotyping based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries; scientific research services; scientific research, namely, development of pharmaceuticals or diagnostic methods for others
Goods and ServicesProviding on-line information in the field of diagnosis and treatment of cancer; providing an on-line computer database featuring information relating to diagnosis and treatment of cancer; providing medical and pharmaceutical information services; providing links to web sites of others featuring information about the diagnosis and treatment of cancer; providing medical information and pharmaceutical information services, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; disease management programs that provide counseling and information in the field of pharmaceuticals, and distributing written materials in connection therewith; providing an interactive website featuring medical information that enables users to enter, access, track, monitor and generate health and medical information and reports; providing pharmacogenetic testing, predictive medical testing, personalized medical testing, gene sequencing-based testing and genotyping, all for medical diagnostic and treatment purposes, based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries
Goods and ServicesGovernment pharmaceutical programs that provide counseling and information to medical professionals, pharmacists and patients, including counseling and information on consumer product safety issues pertaining to pharmaceuticals, and distributing printed materials in connection therewith

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 20, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, March 20, 2013
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, March 20, 2013
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, April 24, 2013
Primary Code045
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events


Event DateEvent Description
Monday, September 12, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 12, 2016ABANDONMENT - NO USE STATEMENT FILED
Friday, January 22, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 21, 2016EXTENSION 5 GRANTED
Tuesday, December 29, 2015EXTENSION 5 FILED
Tuesday, December 29, 2015TEAS EXTENSION RECEIVED
Tuesday, July 28, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 10, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 9, 2015EXTENSION 4 GRANTED
Tuesday, June 30, 2015EXTENSION 4 FILED
Tuesday, June 30, 2015TEAS EXTENSION RECEIVED
Tuesday, January 27, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 26, 2015EXTENSION 3 GRANTED
Monday, January 5, 2015EXTENSION 3 FILED
Monday, January 5, 2015TEAS EXTENSION RECEIVED
Wednesday, August 6, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 5, 2014EXTENSION 2 GRANTED
Tuesday, July 8, 2014EXTENSION 2 FILED
Tuesday, August 5, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 8, 2014TEAS EXTENSION RECEIVED
Thursday, January 9, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 7, 2014EXTENSION 1 GRANTED
Tuesday, January 7, 2014EXTENSION 1 FILED
Tuesday, January 7, 2014TEAS EXTENSION RECEIVED
Tuesday, August 6, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 11, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 11, 2013PUBLISHED FOR OPPOSITION
Wednesday, May 22, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, May 4, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, May 4, 2013ASSIGNED TO LIE
Wednesday, April 24, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 24, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 24, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 24, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 24, 2013NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Wednesday, April 24, 2013EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Wednesday, April 24, 2013COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Wednesday, April 24, 2013EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Tuesday, April 23, 2013NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Tuesday, April 23, 2013EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Tuesday, April 23, 2013COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Tuesday, April 23, 2013EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Wednesday, April 17, 2013ASSIGNED TO EXAMINER
Thursday, March 21, 2013NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, March 20, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, March 18, 2013NEW APPLICATION ENTERED IN TRAM